Study to Assess the Impact of Transitioning Medicare Part B Drugs to Part D

Dynamic List Information
Dynamic List Data
Title
Study to Assess the Impact of Transitioning Medicare Part B Drugs to Part D
Project Officer(s)
Steve Blackwell
Start Date
End Date
Award
Task Order (XRAD)
Description
This task order studies the issues involved with the relationship between Part B and Part D drug coverage. The Secretary's 2005 Report to Congress on Transitioning Medicare Part B Covered Drugs to Part D, mandated under the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA), suggested that there were a limited number of categories of drugs where it might be beneficial to consolidate coverage under one program. However, the Secretary recommended, given the complexity of the issues, that further analyses would be necessary once Medicare had at least two years of experience with the new prescription drug program. This study aims to better understand the financial and programmatic impacts of consolidating certain categories of similar drugs under one program.
Funding
$621,156.00
Principal Investigator(s)
Grecia Marrufo
Project Number
HHSM-500-2006-00006I/0008
Status
A contract was awarded to Acumen in September 2007 to conduct this research. The contractor is presently performing data analysis for the study. An interim report was provided in June, 2009. The base contract has been completed as of October, 2010. The website to the base contract report is as follows: http://www.cms.gov/Reports/Downloads/Acumen_PartBtoDBase_Final_2010.pdf For the option contract, data analysis is currently underway.
Awardee Address

500 Airport Blvd. Suite 365
Burlingame, CA 94010
Estados Unidos

Awardee Name
Acumen, LLC.